Hong Kong Real Estate Stock News

LifeTech Scientific (SEHK:1302) has received official approval from the China National Medical Products Administration for its G-BranchTM thoracoabdominal artery stent graft system. This marks a major regulatory milestone for the company and its medical device portfolio. See our latest analysis for LifeTech Scientific. Even with this breakthrough regulatory approval, LifeTech Scientific’s stock has experienced some choppiness in recent months. While the 1-year total shareholder return sits at...

Semiconductor Manufacturing International Corporation recently announced earnings for the nine months ended September 30, 2025, reporting sales of CNY 49.51 billion and net income of CNY 3.82 billion, both higher than the same period last year. This strong financial result reflects improved business performance and suggests the company may be benefiting from rising demand and operational efficiencies. We'll examine how this substantial revenue and profit growth could influence key elements...

China Galaxy Securities (SEHK:6881) has drawn investor attention with its announcement of a sizable interim cash dividend for the first half of 2025, as well as key governance changes approved at its recent EGM. See our latest analysis for China Galaxy Securities. China Galaxy Securities’ latest moves land amid an impressive run for shareholders, with a 63.75% year-to-date share price return and a 57.70% total shareholder return over the past year. While momentum has cooled in the short term,...

China Overseas Land & Investment Limited announced that in October 2025, contracted property sales fell to approximately RMB 18.66 billion, marking a 55.1% decrease year-on-year, with sales area down by 40%. This significant sales slowdown also contributed to a 21.3% year-on-year decline in accumulated contracted sales for the first ten months of 2025, highlighting pressure on the company's property development business. We will explore how the sharp drop in contracted sales shapes China...

Vobile Group (SEHK:3738) released its latest quarterly results on November 5, highlighting a 27% rise in revenue and 28% growth in monthly recurring revenue as the company sharpens its digital platform and AI strategy. See our latest analysis for Vobile Group. Vobile Group’s recent quarterly surge arrives after a year of powerful gains, with its total shareholder return climbing 36.6% over twelve months. This outpaces the share price’s year-to-date jump of nearly 30%. While shares faced some...

East Buy Holding (SEHK:1797) recently made headlines by subscribing to wealth management products from China Guangfa Bank and China Merchants Bank. This move highlights their strategic approach to managing surplus cash. See our latest analysis for East Buy Holding. Momentum has cooled for East Buy Holding, with a 1-month share price return of -12.62% and a steep 3-month decline. This comes even as investor interest in undervalued Asian stocks grows. Still, shareholders have seen a stellar...

Bank of China recently announced its updated Board of Directors, with Ge Haijiao as Chairman, and revealed the appointment of Mr. Woo Chin Wan Raymond as Independent Non-executive Director from November 7, 2025, following approval from regulators. This focused addition to the board and new committee structure signals the bank’s push to strengthen governance, oversight, and operational effectiveness amid a changing regulatory landscape. We’ll examine how the appointment of a new Independent...

Key Insights C&D International Investment Group's significant public companies ownership suggests that the key...

Innovent Biologics and SanegeneBio recently reported encouraging preliminary results from the first-in-human Phase 1 trial of IBI3016, an experimental siRNA therapy for hypertension, at the 2025 American Heart Association conference. The study showed favorable safety, sustained AGT inhibition, and early antihypertensive effects, underscoring potential progress for innovative treatments in a large unmet market. We'll look at how promising early clinical results with IBI3016 may reshape...

While Man Wah Holdings Limited ( HKG:1999 ) might not have the largest market cap around , it received a lot of...

China Reinsurance (Group) Corporation recently held a board meeting approving substantial amendments to its Articles of Association, driven by changes in Chinese company law and regulatory requirements, including the planned removal of its board of supervisors and updates to compliance and shareholder governance. This restructuring signals a shift in corporate governance, as oversight functions will transition from the board of supervisors to the audit committee, potentially impacting...

Hua Hong Semiconductor recently announced significant leadership changes, with Mr. Peng Bai, the current president, appointed as chairman of the Board and chairman of the nomination committee, while Mr. Junjun Tang resigned from his roles as executive director and chairman, effective October 31, 2025. The consolidation of leadership under Mr. Bai is intended to leverage his semiconductor sector expertise, streamline decision-making, and enhance execution of company strategies during a period...

Simcere Pharmaceutical Group (SEHK:2096) has kicked off Phase II clinical trials in China for SIM0278, its IL-2 mutant fusion protein targeting moderate to severe atopic dermatitis. The new study highlights advances in selective immune therapies. See our latest analysis for Simcere Pharmaceutical Group. Momentum has been surging for Simcere Pharmaceutical Group lately, with the stock posting a 1-day share price return of 7.52% and an 18.01% gain over the past month. Its year-to-date share...

Time Interconnect Technology (SEHK:1729) has updated its agreements with Luxshare Precision and BCS, extending contract terms and increasing annual supply limits. These changes, scheduled to take effect in January 2026, are intended to support growing demand and strengthen shareholder alignment. See our latest analysis for Time Interconnect Technology. The recent contract updates arrive as the stock enjoys significant upward momentum, with a year-to-date share price return of 251.85% and an...

TCL Electronics Holdings (SEHK:1070) closed at HK$9.95, maintaining steady momentum over the past month. Investors have observed a gradual climb as the company’s stock gained 7% across the last week, which reflects renewed interest in the consumer electronics sector. See our latest analysis for TCL Electronics Holdings. The recent rally is part of a larger trend, as TCL Electronics’ solid 1-year total shareholder return of 103% and a sharp year-to-date share price gain of almost 60% show that...

Earlier this week, HSBC initiated coverage on Laopu Gold with a Buy rating, recognizing the company's emergence as a competitive force in the Chinese luxury market. An interesting aspect is Laopu Gold’s estimated 16% market share in mainland China’s high-end jewelry segment for 2024, reflecting rapid expansion against major international rivals. We’ll examine how Laopu Gold’s boutique exclusivity and growing market share shape its investment narrative amid increasing industry...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

As the Asian markets navigate a landscape marked by easing U.S.-China trade tensions and a cautiously optimistic outlook, investors are increasingly on the lookout for opportunities that might be trading below their intrinsic value estimates. In this environment, identifying stocks with strong fundamentals and potential for growth can provide a strategic advantage in building a resilient portfolio.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Shanghai Electric has announced key milestones in controlled nuclear fusion, including the delivery of the world’s largest toroidal field coil case and the arrival of magnet cold-test cryostat equipment at the ITER project site in France. These breakthroughs highlight China’s expanding role in the global fusion supply chain and set new international engineering benchmarks for manufacturing ultra-large core components. We'll explore how recent advancements in delivering critical fusion...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Long term investing works well, but it doesn't always work for each individual stock. We really hate to see fellow...

Key Insights Insiders appear to have a vested interest in EDA Group Holdings' growth, as seen by their sizeable...